These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9846844)

  • 21. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
    Sramek JJ; Leibowitz MT; Weinstein SP; Rowe ED; Mendel CM; Levy B; McMahon FG; Mullican WS; Toth PD; Cutler NR
    J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sibutramine-dependent brown fat activation in rats: an immunohistochemical study.
    Giordano A; Centemeri C; Zingaretti MC; Cinti S
    Int J Obes Relat Metab Disord; 2002 Mar; 26(3):354-60. PubMed ID: 11896490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thermogenic effects of sibutramine and its metabolites.
    Connoley IP; Liu YL; Frost I; Reckless IP; Heal DJ; Stock MJ
    Br J Pharmacol; 1999 Mar; 126(6):1487-95. PubMed ID: 10217544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced weight loss following coadministration of pramlintide with sibutramine or phentermine in a multicenter trial.
    Aronne LJ; Halseth AE; Burns CM; Miller S; Shen LZ
    Obesity (Silver Spring); 2010 Sep; 18(9):1739-46. PubMed ID: 20094043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short-term effects of sibutramine (Reductil) on appetite and eating behaviour and the long-term therapeutic outcome.
    Barkeling B; Elfhag K; Rooth P; Rössner S
    Int J Obes Relat Metab Disord; 2003 Jun; 27(6):693-700. PubMed ID: 12833113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Weight reduction by sibutramine in obese subjects in primary care medicine: the SAT Study.
    Hauner H; Meier M; Wendland G; Kurscheid T; Lauterbach K; ;
    Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):201-7. PubMed ID: 15127325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of sibutramine in addition to diet and exercise on the relationship between weight loss and blood glucose changes.
    Kamil S; Finer N; James WPT; Caterson ID; Andersson C; Torp-Pedersen C
    Eur Heart J Cardiovasc Pharmacother; 2017 Jul; 3(3):134-139. PubMed ID: 27680881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of sibutramine on body weight and serum lipids: a double-blind, randomized, placebo-controlled study in 322 overweight and obese patients with dyslipidemia.
    Dujovne CA; Zavoral JH; Rowe E; Mendel CM;
    Am Heart J; 2001 Sep; 142(3):489-97. PubMed ID: 11526363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors.
    McMahon FG; Weinstein SP; Rowe E; Ernst KR; Johnson F; Fujioka K;
    J Hum Hypertens; 2002 Jan; 16(1):5-11. PubMed ID: 11840224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Locomotion is the major determinant of sibutramine-induced increase in energy expenditure.
    Golozoubova V; Strauss F; Malmlöf K
    Pharmacol Biochem Behav; 2006 Apr; 83(4):517-27. PubMed ID: 16647108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of sibutramine treatment on sympathetic vasomotor tone in obese subjects.
    Heusser K; Tank J; Diedrich A; Engeli S; Klaua S; Krüger N; Strauss A; Stoffels G; Luft FC; Jordan J
    Clin Pharmacol Ther; 2006 May; 79(5):500-8. PubMed ID: 16678551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of caffeine, green tea and tyrosine on thermogenesis and energy intake.
    Belza A; Toubro S; Astrup A
    Eur J Clin Nutr; 2009 Jan; 63(1):57-64. PubMed ID: 17882140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety comparative evaluation of orlistat and sibutramine treatment in hypertensive obese patients.
    Derosa G; Cicero AF; Murdolo G; Piccinni MN; Fogari E; Bertone G; Ciccarelli L; Fogari R
    Diabetes Obes Metab; 2005 Jan; 7(1):47-55. PubMed ID: 15642075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of sibutramine on weight loss and blood pressure: a meta-analysis of controlled trials.
    Kim SH; Lee YM; Jee SH; Nam CM
    Obes Res; 2003 Sep; 11(9):1116-23. PubMed ID: 12972682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sibutramine promotes amygdala activity under fasting conditions in obese women.
    Oltmanns KM; Heldmann M; Daul S; Klose S; Rotte M; Schäfer M; Heinze HJ; Münte TF; Lehnert H
    Psychopharmacology (Berl); 2012 Jun; 221(4):693-700. PubMed ID: 22193727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of 2-week ingestion of (--)-hydroxycitrate and (--)-hydroxycitrate combined with medium-chain triglycerides on satiety, fat oxidation, energy expenditure and body weight.
    Kovacs EM; Westerterp-Plantenga MS; Saris WH
    Int J Obes Relat Metab Disord; 2001 Jul; 25(7):1087-94. PubMed ID: 11443511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of sibutramine on binge eating, hunger, and fullness in a laboratory human feeding paradigm.
    Mitchell JE; Gosnell BA; Roerig JL; de Zwaan M; Wonderlich SA; Crosby RD; Burgard MA; Wambach BN
    Obes Res; 2003 May; 11(5):599-602. PubMed ID: 12740447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of metabolic effects of orlistat and sibutramine treatment in Type 2 diabetic obese patients.
    Derosa G; Cicero AF; Murdolo G; Ciccarelli L; Fogari R
    Diabetes Nutr Metab; 2004 Aug; 17(4):222-9. PubMed ID: 15575343
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sibutramine and thermogenesis in humans.
    Danforth E
    Int J Obes Relat Metab Disord; 1999 Oct; 23(10):1007-8. PubMed ID: 10557019
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of obese adolescents with sibutramine: a randomized, double-blind, controlled study.
    Godoy-Matos A; Carraro L; Vieira A; Oliveira J; Guedes EP; Mattos L; Rangel C; Moreira RO; Coutinho W; Appolinario JC
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1460-5. PubMed ID: 15613431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.